COVID-19 tracker: Omicron booster nods expected Wednesday
March 2020 – BioHealth Capital Region
Articles with Vaxart, Inc.
Biomedicines | Free Full-Text | Counting on COVID-19 Vaccine: Insights into the Current Strategies, Progress and Future Challenges
Vaxart, Inc. – SEC Filing
Frontiers | Development and Application of a Novel Rapid and Throughput Method for Broad-Spectrum Anti-Foodborne Norovirus Antibody Testing
The pandemic pipeline
avir20170630_10k.htm
SARS-CoV-2 Vaccine Development: An Overview and Perspectives | ACS Pharmacology & Translational Science
Vaxart: A Unique Vaccine Concern (NASDAQ:VXRT) | Seeking Alpha
Vaxart (VXRT): Great Potential But Issues Remain | Seeking Alpha
Prevention of host-to-host transmission by SARS-CoV-2 vaccines - The Lancet Infectious Diseases
Novavax - News, Articles etc. - European Pharmaceutical Review
Vaxart to Present at the SVB Leerink CybeRx Series: Vaccine Forum
COVID-19 vaccines: where we stand and challenges ahead | Cell Death & Differentiation
Bioengineering | Free Full-Text | COVID-19 Vaccines: An Updated Overview of Different Platforms
Vaccines | Free Full-Text | Drop the Needle; A Temperature Stable Oral Tablet Vaccine Is Protective against Respiratory Viral Pathogens
Vaxart, Inc. – SEC Filing
Vaxart stock slips more than 8% as Q3 expenses jump, cash position deteriorates | Seeking Alpha
